1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

Blog | Chemxpert

Biosimilars

Top Biosimilar Companies in India | Reasons for Biosimilar Growth in India and Future

Admin
Biosimilars
22 July 2025

Did you know that over $200 billion worth of biologic drugs are about to lose their patents by 2030.Read More

Why Most Biosimilars don’t get Approved?

Admin
Biosimilars
10 July 2025

Explore 2025 biosimilar approval trends, regional bottlenecks, and why most applications fail despite rising global market demand.Read More

Biosimilar Approvals in 2025: Key FDA Trends, Interchangeables & Industry Outlook

Admin
Biosimilars
25 June 2025

As we move deeper into 2025, biosimilars are gaining unprecedented traction.Read More

Biosimilars Market Outlook 2025: Trends, Growth Drivers, and Key Players Shaping the Future

Admin
Biosimilars
3 June 2025

Biosimilars are near-identical versions of approved biologics, offering similar safety, efficacy, and quality—but at a lower cost. Unlike generics, biosimilars are made from living cells and require complex development and regulatory approval.Read More

Biosimilars

Top Biosimilar Companies in India | Reasons for Biosimilar Growth in India and Future

Why Most Biosimilars don’t get Approved?

Biosimilar Approvals in 2025: Key FDA Trends, Interchangeables & Industry Outlook

Biosimilars Market Outlook 2025: Trends, Growth Drivers, and Key Players Shaping the Future

Latest News

Recent Post

Category